The two companies collaborated on research showing quantum computing could greatly aid the design of mRNA-based medicines and ...

President Donald Trump's proposed budget cuts to the National Institutes of Health would eventually result in fewer drugs on ...

The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...

Biotech veteran and Stanford physician-scientist brings 30 years of translational research and regulatory experience to ...

The U.S. Food and Drug Administration said on Monday it has appointed George Tidmarsh, a seasoned biotech executive and ...

With the rise of advanced simulation and model-informed drug development (MIDD) techniques like digital twins, researchers ...

Researchers at NYU Tandon School of Engineering have developed a new method for creating microscopic drug delivery capsules ...

The U.S. Food and Drug Administration has appointed George Francis Tidmarsh, M.D., Ph.D., as director of the Center for Drug Evaluation and Research (CDER).

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...

“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...

One of the few drug trials for a possible long Covid ended in disappointment. But lessons are leading to a second chance.